Table 1 Clinical features, laboratory findings including next-generation sequencing results, and outcome of patients with Rosai–Dorfman disease

From: Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai–Dorfman disease

Patient no.

Age a (years)

Sex

B-symptoms

LAD

HSM

Nodal

Extranodal

Stage

WBC (× 10 9 /l)

HGB (g/dl)

PLT (K/μl)

LDH (IU/l)

B2M (mg/l)

Mutations detected by NGS

p-ERK IHC

Therapy

FU (m)

Outcome

1

4

F

No

Yes

No

Cervical

Orbital

Multifocal

7.5

12.1

380

591

NA

KRAS c.351 A>T p.K117N

N

Multiple including cladribine

141

CR

2

32

F

No

No

No

No

Soft tissue of trunk

Unifocal

6

12.7

257

333

1.6

None

N

Resection, radiation

142

CR

3

34

F

NA

NA

NA

No

Soft tissue of trunk

NA

NA

NA

NA

NA

NA

KRAS c.64C>A p.Q22K

N

NA

NA

NA

4

7

F

No

Yes

No

Multi-compartment

Paranasal sinuses, lung, bone

Multifocal

5.6

11.5

352

403

1.9

MAP2K1, c.371C>G p.P124R

P

Multiple including radiation and cladribine

352

CR

              

CDH1, c.211C>T p.L71F

    

5

21

F

No

No

No

No

Breast

Unifocal

3.8

11.9

287

388

NA

None

N

Resection

16

PD

6

82

M

Yes

Yes

Yes

Inguinal

No

Unifocal

NA

NA

NA

NA

NA

None

NA

NA

NA

NA

7

53

M

No

No

No

No

Base of skull, orbital

Multifocal

7.1

15.8

250

424

NA

KRAS 35G>A p.G12D

N

Resection

7

CR

8

68

M

No

Yes

No

No

Extranodal soft tissueb

Unifocal

18.3

12.5

283

398

NA

None

N

Resection

54

CR

9

53

F

NA

NA

NA

No

Breast

NA

NA

NA

NA

NA

NA

None

NA

NA

NA

NA

10

64

M

No

No

No

No

Bone of upper extremity, nasopharynx, paranasal sinuses

Multifocal

7.3

13.9

185

443

2.4

None

N

Multiple including resection, radiation & cladribine

94

PD

11

3

M

NA

Yes

NA

Cervical

No

NA

NA

NA

NA

NA

NA

MAP2K1 c.157 T>G p.F53V

P

NA

NA

NA

12

64

M

No

Yes

NA

Multi-compartment

Nasopharynx

Multifocal

2.4

11.9

74

372

NA

MAP2K1 c.383G>A p.G128D

P

Resection, radiation, Cladribine

74

PD

13

10

F

No

Yes

No

No

Base of skull, adenoids, nasopharynx

Multifocal

16.3

15.1

272

NA

NA

KRAS c.436G>A p.A146T

N

Resection

26

CR

14

35

F

No

Yes

No

No

Soft tissue of lower extremity

Multifocal

NA

NA

NA

NA

NA

None

N

NA

NA

NA

15

61

F

NA

NA

NA

No

Soft tissue of trunk

NA

NA

NA

NA

NA

NA

None

N

NA

NA

NA

16

53

F

No

No

No

No

Breast

Unifocal

9

11.6

288

520

2

None

N

Resection

154

CR

17

43

F

NA

NA

NA

No

Soft tissue of trunk

Unifocal

NA

NA

NA

NA

NA

None

N

NA

NA

NA

18

36

M

NA

NA

NA

No

Soft tissue of upper extremity

NA

NA

NA

NA

NA

NA

None

N

NA

NA

NA

19

4

F

Yes

Yes

NA

Multi-compartment

No

Multifocal

NA

NA

NA

NA

NA

None

N

NA

NA

NA

20

63

F

NA

Yes

NA

Cervical

No

Unifocal

NA

NA

NA

NA

NA

None

N

NA

NA

NA

21

72

M

NA

Yes

NA

Cervical

No

Unifocal

NA

NA

NA

NA

NA

None

N

NA

NA

NA

  1. B2M, beta-2-microglobulin; CR, complete remission; F, female; FU, follow-up; HGB, hemoglobin; HSM, hepatosplenomegaly; IHC, immunohistochemistry; LAD, lymphadenopathy; LDH, lactate dehydrogenase; m, months; M, male; N, negative; NA, not available; NGS, next-generation sequencing; P, positive; PD, persistent disease; PLT, platelets; WBC, white blood cells.
  2. aAge indicates age at initial diagnosis.
  3. bIncidental finding in the soft tissue surrounding a mesenteric lymph node removed for staging of prostatic carcinoma.